Roy Gulick, Weill Cornell Medical College, New York
Although the logic in antiretroviral HIV therapy has, for some years, been that two drugs are better than one; and three are better than two, this has not continued. A late breaking study involving 700 patients presented on this at ICAAC found that four drugs are not better than three, but that a worrying relationship exists between race and time to virologic failure.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.